Charles Bidgood
Positions
- PhD Candidate (Cancer Metabolism), APCRC-Q
- Centre for Genomics and Personalised Health, QUT
- School of Biomedical Sciences, Faculty of Health, QUT
Related websites and profiles
Qualifications
Bachelor of Biomedical Science (Honours), Queensland University of Technology, Australia, 2018
Bachelor of Biomedical Science (Human Physiology), Queensland University of Technology, Australia, 2017
Biography
Charles’ has been working with the APCRC-Q since 2018 where he joined as an honour’s student under the supervision of Jennifer Gunter, Martin Sadowski, Rohan Davis, and Colleen Nelson. His project involved investigating the use of naturally derived compounds to target prostate cancer metabolism. Here he developed a diverse skillset which included the implementation of high-content fluorescent microscopy and the generation of advanced image segmentation pipelines. In 2019, he began a PhD which was funded through the Australian Government Research Training Program (RTP) and is currently in his final year of research. His project involves investigating the complex metabolic landscape associated with advanced prostate cancer and the development of therapeutic resistance.
Awards and grants
|
2021 |
Heat Winner, QUT Biomedical Sciences 3 Minute Thesis Competition |
|
2021 |
Best Speaker Award, TRI Student Seminar Series |
|
2019 |
Australian Government Research Training Program (RTP) Scholarship |
|
2017 |
Vacation Research Experience Scheme (VRES) Scholarship |
|
2017 |
QUT Executive Dean's Commendation Award |
Research interests
Prostate cancer, metabolism, fluorescent microscopy, bioinformatics
Current research projects
Valine Catabolism Reprogramming Promotes Therapeutic Resistance in Advanced Prostate Cancer
Top publications
Kumar, R., Bidgood, C. L., Levrier, C., Gunter, J. H., Nelson, C. C., Sadowski, M. C., & Davis, R. A. (2020). Synthesis of a Unique Psammaplysin F Library and Functional Evaluation in Prostate Cancer Cells by Multiparametric Quantitative Single Cell Imaging. Journal of Natural Products, 83(8), 2357–2366. https://doi.org/10.1021/acs.jnatprod.0c00121
Young, R. S. E., Bowman, A. P., Williams, E. D., Tousignant, K. D., Bidgood, C. L., Narreddula, V. R., Gupta, R., Marshall, D. L., Poad, B. L. J., Nelson, C. C., Ellis, S. R., Heeren, R. M. A., Sadowski, M. C., & Blanksby, S. J. (2021). Apocryphal FADS2 activity promotes fatty acid diversification in cancer. Cell Reports, 34(6), 108738. https://doi.org/10.1016/j.celrep.2021.108738
Philp, L. K., Rockstroh, A., Sadowski, M. C., Taherian Fard, A., Lehman, M., Tevz, G., Libério, M. S., Bidgood, C. L., Gunter, J. H., McPherson, S., Bartonicek, N., Wade, J. D., Otvos Jr, L., & Nelson, C. C. (2021). Leptin antagonism inhibits prostate cancer xenograft growth and progression. Endocrine-Related Cancer. https://doi.org/10.1530/erc-20-0405
More can be viewed on Pubmed.
Collaborators
- Colleen Nelson AM Executive Director, APCRC-Q
- Jennifer Gunter Senior Research Associate (Cancer Metabolism), APCRC-Q
- Lisa Philp Postdoctoral Research Fellow (Adipokines), APCRC-Q
- Martin Sadowski Postdoctoral Research Fellow
Professional memberships and associations
|
2021-present |
Australian Society of Medical Research (ASMR) |
